Education
About Us
Working with TipRanks
Follow Us
Dr. Hoenle AG (GB:0O27)
:0O27
0O27 Analyst Ratings
Currently, no data available
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
0O27 Stock 12 Month Forecast
There Are No Analyst Ratings for GB:0O27 In The Last 3 Months.
| Highest Price Target― | Average Price Target― | Lowest Price Target― |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
0O27 Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TR | OpenAI - 4o
€8.5
Hold
4.68%
Upside
Reiterated
10/14/25
AI Generated ArticleAI Generated Article
Warburg Research
€22
Buy
170.94%
Upside
Reiterated
11/22/24
We assume that goodwill amortisation will amount to EUR 7-8m and are hence attributing the vast majority to the write-downs. At the end of FY 2023, Hönle had goodwill of EUR 18m in its balance sheet. Of this roughly EUR 6m can be attributed to Hoenle AG and Raesch Malta respectively and another EUR 5m to Sterilsystems. As the disinfection business is not expected to be affected by the measures, the sources of the goodwill amortisation are expected to have been Hoenle AG, with its higher exposure to printing customers, and Raesch Malta, where profitability has been stable but at low levels. Organically, Hönle reached sales of EUR 98m and a slightly positive EBIT in FY 2024, which is in line with the expectation. The operating development is expected to have troughed in the last FY.
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TR | OpenAI - 4o
€8.5
Hold
4.68%
Upside
Reiterated
10/14/25
AI Generated ArticleAI Generated Article
Warburg Research
€22
Buy
170.94%
Upside
Reiterated
11/22/24
We assume that goodwill amortisation will amount to EUR 7-8m and are hence attributing the vast majority to the write-downs. At the end of FY 2023, Hönle had goodwill of EUR 18m in its balance sheet. Of this roughly EUR 6m can be attributed to Hoenle AG and Raesch Malta respectively and another EUR 5m to Sterilsystems. As the disinfection business is not expected to be affected by the measures, the sources of the goodwill amortisation are expected to have been Hoenle AG, with its higher exposure to printing customers, and Raesch Malta, where profitability has been stable but at low levels. Organically, Hönle reached sales of EUR 98m and a slightly positive EBIT in FY 2024, which is in line with the expectation. The operating development is expected to have troughed in the last FY.
Best Analysts Covering Dr. Hoenle AG
1 Month
xxx
Success Rate
13/19 ratings generated profit
Average Return
+4.29%
reiterated a xxx
rating 12 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 68.42% of your transactions generating a profit, with an average return of +4.29% per trade.
3 Months
xxx
Success Rate
8/19 ratings generated profit
Average Return
+2.07%
reiterated a xxx
rating 12 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 42.11% of your transactions generating a profit, with an average return of +2.07% per trade.
1 Year
Success Rate
8/19 ratings generated profit
Average Return
-12.33%
reiterated a buy rating 12 months ago
Copying Malte Schaumann's trades and holding each position for 1 Year would result in 42.11% of your transactions generating a profit, with an average return of -12.33% per trade.
2 Years
xxx
Success Rate
0/19 ratings generated profit
Average Return
-34.38%
reiterated a xxx
rating 12 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -34.38% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
0O27 Analyst Recommendation Trends
Rating
May 25
Jun 25
Jul 25
Aug 25
Oct 25
Strong Buy
1
0
0
0
0
Buy
0
0
0
0
0
Hold
4
7
9
9
10
Sell
0
0
0
1
1
Strong Sell
0
0
0
0
0
total
5
7
9
10
11
Each month's total comprises the sum of three months' worth of ratings.
0O27 Stock Forecast FAQ
What is GB:0O27’s average 12-month price target, according to analysts?
Currently, no data Available
What is GB:0O27’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for GB:0O27, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Dr. Hoenle AG a Buy, Sell or Hold?
Currently, no data Available
What is Dr. Hoenle AG’s share price target?
Currently, no data Available
What do analysts say about Dr. Hoenle AG?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Dr. Hoenle AG?
To buy shares of GB:0O27, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.